Xilio Therapeutics, Inc.XLONASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P36
Within normal range
vs 2Y Ago
-1.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | -20.85% |
| Q2 2025 | -149.96% |
| Q1 2025 | 304.69% |
| Q4 2024 | -3.55% |
| Q3 2024 | -168.52% |
| Q2 2024 | 289.99% |
| Q1 2024 | 21.78% |
| Q4 2023 | -0.43% |
| Q3 2023 | 19.34% |
| Q2 2023 | 34.36% |
| Q1 2023 | -38.56% |
| Q4 2022 | 8.47% |
| Q3 2022 | -18.82% |
| Q2 2022 | 19.58% |
| Q1 2022 | -21.40% |
| Q4 2021 | 17.17% |
| Q3 2021 | -2.90% |
| Q2 2021 | 11.43% |
| Q1 2021 | -78.94% |
| Q4 2020 | -21.45% |
| Q3 2020 | -130368.94% |
| Q2 2020 | -63.40% |
| Q1 2020 | 0.00% |